Ask Todd Smith Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Pastimes : Ask Todd Smith

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: nigel bates who wrote (38)	4/26/2001 1:28:35 PM
From: scaram(o)uche	Read Replies (1) of 53

Tough enough business, even when patients get what they're supposed to get. Yeah, there was a clever turn in the middle of one sentence there, huh? "Importantly, IntraBiotics said that Protegrin IB-367 Rinse did meet the secondary endpoint of reducing patients' peak pain by 19% for the intent-to-treat group (p<0.05) and by 21% in the smaller, properly treated group (p=0.13)." "Intrabiotics said"???? This isn't a Reuter's rehash, Kelly. This is YOUR press release.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next